BIOMAT Database Logo BIOMAT Database Logo

Epidermal growth factor and phorbol myristate acetate increase expression of the mRNA for cytosolic phospholipase A2 in glomerular mesangial cells. 1993

A P Maxwell, and H J Goldberg, and A H Tay, and Z G Li, and G S Arbus, and K L Skorecki
Department of Medicine, University of Toronto, Ontario, Canada.

We have previously shown that phospholipase A2 (PLA2) activity is rapidly activated by epidermal growth factor (EGF) and phorbol 12-myristate 13-acetate (PMA) in renal mesangial cells and other cell systems in a manner that suggests a covalent modification of the PLA2 enzyme(s). This PLA2 activity is cytosolic (cPLA2) and is distinct from secretory forms of PLA2, which are also stimulated in mesangial cells in response to cytokines and other agonists. However, longer-term regulation of cPLA2 in renal cells may also occur at the level of gene expression. Cultured rat mesangial cells were used as a model system to test the effects of EGF and PMA on the regulation of cPLA2 gene expression. EGF and PMA both produced sustained increases in cPLA2 mRNA levels, with a parallel increase in enzyme activity over time. Inhibition of protein synthesis by cycloheximide increased basal cPLA2 mRNA accumulation in serum-starved mesangial cells, and the combination of EGF and cycloheximide resulted in super-induction of cPLA2 gene expression compared with EGF alone. Actinomycin D treatment entirely abrogated the effect of EGF on cPLA2 mRNA accumulation. These findings suggest that regulation of cPLA2 is achieved by factors controlling gene transcription and possibly mRNA stability, in addition to previously characterized posttranslational modifications.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D010741 Phospholipases A Phospholipases that hydrolyze one of the acyl groups of phosphoglycerides or glycerophosphatidates.
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003513 Cycloheximide Antibiotic substance isolated from streptomycin-producing strains of Streptomyces griseus. It acts by inhibiting elongation during protein synthesis. Actidione,Cicloheximide
D003600 Cytosol Intracellular fluid from the cytoplasm after removal of ORGANELLES and other insoluble cytoplasmic components. Cytosols
D003609 Dactinomycin A compound composed of a two CYCLIC PEPTIDES attached to a phenoxazine that is derived from STREPTOMYCES parvullus. It binds to DNA and inhibits RNA synthesis (transcription), with chain elongation more sensitive than initiation, termination, or release. As a result of impaired mRNA production, protein synthesis also declines after dactinomycin therapy. (From AMA Drug Evaluations Annual, 1993, p2015) Actinomycin,Actinomycin D,Meractinomycin,Cosmegen,Cosmegen Lyovac,Lyovac-Cosmegen,Lyovac Cosmegen,Lyovac, Cosmegen,LyovacCosmegen
D004815 Epidermal Growth Factor A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. Epidermal growth factor exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and EPITHELIAL CELLS. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form. EGF,Epidermal Growth Factor-Urogastrone,Urogastrone,Human Urinary Gastric Inhibitor,beta-Urogastrone,Growth Factor, Epidermal,Growth Factor-Urogastrone, Epidermal,beta Urogastrone
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D005920 Glomerular Mesangium The thin membranous structure supporting the adjoining glomerular capillaries. It is composed of GLOMERULAR MESANGIAL CELLS and their EXTRACELLULAR MATRIX. Mesangium, Glomerular,Mesangial Extracellular Matrix,Extracellular Matrices, Mesangial,Extracellular Matrix, Mesangial,Glomerular Mesangiums,Matrices, Mesangial Extracellular,Matrix, Mesangial Extracellular,Mesangial Extracellular Matrices,Mesangiums, Glomerular
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

A P Maxwell, and H J Goldberg, and A H Tay, and Z G Li, and G S Arbus, and K L Skorecki
Epidermal growth factor stimulates phospholipase A2 in vasopressin-treated rat glomerular mesangial cells.
December 1988, The Biochemical journal,
A P Maxwell, and H J Goldberg, and A H Tay, and Z G Li, and G S Arbus, and K L Skorecki
Epidermal growth factor enhances glomerular mesangial cell soluble phospholipase A2 activity.
March 1990, The Journal of biological chemistry,
A P Maxwell, and H J Goldberg, and A H Tay, and Z G Li, and G S Arbus, and K L Skorecki
Endothelin-1 stimulates cytosolic phospholipase A2 activity and gene expression in rat glomerular mesangial cells.
December 1994, Kidney international,
A P Maxwell, and H J Goldberg, and A H Tay, and Z G Li, and G S Arbus, and K L Skorecki
Vascular endothelial growth factor mRNA in pericytes is upregulated by phorbol myristate acetate.
January 1998, Hypertension (Dallas, Tex. : 1979),
A P Maxwell, and H J Goldberg, and A H Tay, and Z G Li, and G S Arbus, and K L Skorecki
Cytokine regulation of group II phospholipase A2 expression in glomerular mesangial cells.
January 1993, European journal of clinical pharmacology,
A P Maxwell, and H J Goldberg, and A H Tay, and Z G Li, and G S Arbus, and K L Skorecki
Regulation of cytosolic phospholipase A2 in rat endometrial stromal cells: the role of epidermal growth factor.
April 1999, Molecular reproduction and development,
A P Maxwell, and H J Goldberg, and A H Tay, and Z G Li, and G S Arbus, and K L Skorecki
Cross-talk between secretory phospholipase A2 and cytosolic phospholipase A2 in rat renal mesangial cells.
October 1997, Biochimica et biophysica acta,
A P Maxwell, and H J Goldberg, and A H Tay, and Z G Li, and G S Arbus, and K L Skorecki
A role for G-proteins in the epidermal growth factor stimulation of phospholipase A2 in rat kidney mesangial cells.
August 1990, Bioscience reports,
A P Maxwell, and H J Goldberg, and A H Tay, and Z G Li, and G S Arbus, and K L Skorecki
Epidermal growth factor coordinately regulates the expression of prostaglandin G/H synthase and cytosolic phospholipase A2 genes in embryonic mouse cells.
August 1994, The Journal of biological chemistry,
A P Maxwell, and H J Goldberg, and A H Tay, and Z G Li, and G S Arbus, and K L Skorecki
Thrombin, epidermal growth factor, and phorbol myristate acetate stimulate tubulin polymerization in quiescent cells: a potential link to mitogenesis.
January 1992, Cell motility and the cytoskeleton,
Copied contents to your clipboard!